The unavailability of medicines can be both problematic and lead to severe consequences for patients in need of therapy. However, in many cases other treatment alternatives can be provided. Quantify, in collaboration […]
Quantify’s Emma Söreskog, Ingrid Lindberg, Oskar Ström and Fredrik Borgström have co-authored two recently published papers on cost-effectiveness modelling in osteoporosis. One of the papers presents a […]
A new systematic literature review on patient quality of life in Alzheimer’s disease is now published. The study was co-authored by Anders Gustavsson and is part of the Innovative Medicines Initiative project […]
Quantify’s Ingrid, Mathias and Kirk are co-authors on an population-based Swedish RWE study of incidence of psoriaticarthritis in adults with skin psoriasis published in Acta D-V, and presented at AAD2020. The results showed that if 10,000 patients with skin psoriasis […]
Anders Gustavsson is co-author of a recently published Alzheimer study presenting a cross-walk between the generic health utility measure EQ5D and the disease specific health-related quality of life measure QoL-AD.
A free full text version is available here.
The paper “Association of Skin Psoriasis and Somatic Comorbidity With the Development of Psychiatric Illness in a Nationwide Swedish Study” by Quantify’s Kirk Geale and coauthors has been published in JAMA Dermatology. […]
The abstract “Persistence of biologic treatment in psoriatic arthritis: A population-based study in Sweden”, co-authored by Quantify’s Kirk Geale, Ingrid Lindberg and Emma Paulsson, has been accepted for oral presentation at EULAR 2020 E-Congress on June 3rd at 16:30-16:35, Session […]
The paper “Statin Dose Titration Patterns and Subsequent Major Cardiovascular Events in very High-Risk Patients – Estimates from Swedish Population-based Registry Data”, co-authored by Quantify’s Jonas Banefelt and Maria Lindh has been published in European Heart Journal – Quality of […]
The paper ‘Fragility fractures in Europe: burden, management and opportunities’, co-authored by Quantify’s Fredrik Borgström, Linda Karlsson, Gustaf Ortsäter and Nicholas Norton, has been published in Archives of Osteoporosis.
The paper ‘Cost-Effectiveness Analysis of Patiromer in Combination with Renin–Angiotensin–Aldosterone System Inhibitors for Chronic Kidney Disease in Sweden’, co-authored by Quantify, has been published in PharmacoEconomics. Read the full article here.
